You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cabozantinib

Showing 26 - 50 of 128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Adult Hepatocellular Carcinoma Trial in Chicago, Ann Arbor, Dallas (Cabozantinib)

Recruiting
  • Advanced Adult Hepatocellular Carcinoma
  • Cabozantinib
  • Chicago, Illinois
  • +3 more
Aug 15, 2022

Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

Recruiting
  • Metastatic Hormone Refractory Prostate Cancer
  • Cabozantinib
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 6, 2022

Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)

Recruiting
  • Bladder Cancer
  • Cabozantinib
  • +2 more
  • Hackensack, New Jersey
  • +4 more
Aug 26, 2022

Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)

Recruiting
  • Refractory Cutaneous Melanoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 8, 2022

Prostate Cancer Trial in Detroit, New York (Cabozantinib)

Recruiting
  • Prostate Cancer
  • Cabozantinib
  • Detroit, Michigan
  • +2 more
Mar 30, 2022

Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Bladder Cancer
  • Tampa, Florida
  • +2 more
Jun 9, 2022

Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)

Recruiting
  • Neuroendocrine Tumors
  • Neuroendocrine Carcinoma
  • Cabozantinib
  • Göttingen, Lower Saxony, Germany
  • +5 more
Jun 27, 2022

Pancreatic Cancer Trial in Lexington (Cabozantinib, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Feb 26, 2022

d To Treat People With Renal Cell Carcinoma

Recruiting
  • Renal Cell Carcinoma
  • Cabozantinib
  • Tokyo, Japan
    Takeda Selected Site
Apr 26, 2022

Carcinoma Prostate Trial in Brescia (Cabozantinib)

Recruiting
  • Carcinoma Prostate
  • Cabozantinib
  • Brescia, Italy
    Alfredo Berruti
Mar 2, 2022

Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Philadelphia (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Cabozantinib
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 2, 2022

Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma

Active, not recruiting
  • Renal Cell Carcinoma
  • Cabozantinib
  • Padova, Italy
    Istituto Oncologico Veneto
Feb 7, 2022

Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)

Completed
Has Results
  • Prostate Cancer
  • Cabozantinib
  • Androgen Ablation Therapy
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange (Cabozantinib, Pembrolizumab)

Recruiting
  • Gastric Adenocarcinoma
  • GastroEsophageal Cancer
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022

NF1, Neurofibromatosis, Plexiform Neurofibromas Trial in United States (Cabozantinib)

Active, not recruiting
  • NF1
  • +2 more
  • Cabozantinib
  • Los Angeles, California
  • +11 more
Jan 13, 2023

Head and Neck Squamous Cell Cancer, Recurrent Head and Neck Squamous Cell Cancer, Metastatic Head and Neck Squamous Cell Cancer

Active, not recruiting
  • Head and Neck Squamous Cell Cancer
  • +2 more
  • Miami, Florida
  • +8 more
Dec 2, 2022

Renal Cell Carcinoma Trial (Cabozantinib, Ipilimumab, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • Cabozantinib
  • +4 more
  • (no location specified)
Jun 9, 2022

Hepatocellular Carcinoma, HCC Trial in Orange (Nivolumab, Ipilimumab, Cabozantinib)

Recruiting
  • Hepatocellular Carcinoma
  • HCC
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022

Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)

Not yet recruiting
  • Neuroendocrine Tumors
  • Portland, Oregon
    Providence Portland Cancer Institute - Franz Clinic
Feb 10, 2022

Non Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Urothelial Carcinoma Trial in Augusta (Cabozantinib,

Recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Mar 6, 2022

Hepatocellular Carcinoma Trial in Dresden, Leipzig, Berlin (Cabozantinib)

Recruiting
  • Hepatocellular Carcinoma
  • Cabozantinib
  • Dresden, Saxonia, Germany
  • +2 more
Mar 10, 2022

Breast Cancer Trial in Boston (Nivolumab, Cabozantinib)

Completed
Has Results
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 29, 2021

Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)

Recruiting
  • Carcinoid Tumor
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 14, 2022

High Grade Neuroendocrine Tumors Trial in Saint Louis (Cabozantinib, Blood for plasma biomarkers, Tissue biopsy)

Recruiting
  • High Grade Neuroendocrine Neoplasms
  • Cabozantinib
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 11, 2021

Advanced/Metastatic Cervical Cancer Trial in France (Cabozantinib)

Active, not recruiting
  • Advanced/Metastatic Cervical Cancer
  • Cabozantinib
  • Angers, France
  • +7 more
Dec 29, 2021